Novo Holdings is encountering more resistance as it aims to close its $16.5 billion acquisition of pharma manufacturing giant ...

The firms entered into a merger agreement in February for Novo Holdings to acquire Catalent in an all-cash transaction worth $16.5 billion. That deal still expects to close toward the end of ...

and inventory management for drugs and biologics in clinical trials. The company was founded in April 2007 and is headquartered in Somerset, NJ. Read More on CTLT: Catalent NewsMORE Related Stocks ...

Public interest groups are urging the FTC to block Novo Holdings' $16.5 billion acquisition of Catalent, citing concerns over ...

Catalent (NYSE:CTLT) is selling its oral solids development and small-scale manufacturing facility in Somerset, New Jersey to contract manufacturer Ardena. Financial details of the agreement ...

On Friday, Catalent Inc (CTLT) stock saw a modest uptick, ending the day at $60.29 which represents a slight increase of $0.20 or 0.33% from the prior close of $60.09. The stock opened at $60 and ...

Awaiting a potential acquisition by Novo Holdings, Catalent is giving its contract manufacturing compatriot a boost as Ardena plots its U.S. debut. Catalent is selling its oral solids development ...

Catalent Price Performance NYSE CTLT opened at $60.65 on Tuesday. The company has a market cap of $10.98 billion, a PE ratio of -9.94, a price-to-earnings-growth ratio of 2.14 and a beta of 1.15 ...

(Reuters) - Catalent has agreed to sell its oral drug development and small-scale manufacturing facility in Somerset, New Jersey to private contract drug manufacturer Ardena, the companies said on ...

Fintel reports that on September 24, 2024, Baird downgraded their outlook for Catalent (NYSE:CTLT) from Outperform to Neutral ...

Pace Life Sciences, a division of the broader Pace organization, has acquired a laboratory in Morrisville from Catalent (NYSE: CTLT) that focuses on analytical services. Catalent is a contract ...

A Catalent spokesperson reiterated the company's position on the deal in a statement on Friday to Reuters in response to the letter: "Novo Holdings’ pending acquisition of Catalent will further ...